1.
What is the primary active compound in the oleander extract discussed in the webinar?
1 out of 6
2.
With a dose of 4-5 µg/kg was found to be safe in the study reported, at what dose was a fatal arrhythmia seen in one dog?
2 out of 6
3.
Oleander as an indirect antiviral works through what mechanism?
3 out of 6
4.
Which mechanism of action contributes to oleander's therapeutic effects?
4 out of 6
5.
Which delivery methods for oleander-based products were discussed in the webinar?
5 out of 6
6.
What is the primary benefit of oleander that is not a benefit of oclacitinib?
6 out of 6
